AzTrials
AzTrials

BreastfeedingNCT07030491

The Effect of Lactation Cookies on Breastfeeding Outcomes in Lactating Women

A study testing Lactation Cookies in people with Breastfeeding, run by Notre Dame University - Louaize at 1 site in Lebanon.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if eating lactation cookies can help breastfeeding women make more milk. The main questions it aims to answer are: Do lactation cookies help increase milk production? Do lactation cookies make the breastfeeding experience easier or better? Researchers will compare lactation… Read more about this study

Who is it for?
Ages 18 to 45 years, women onlyHealthy volunteers can take part
Conditions the study is for
Breastfeeding
What is being tested?
Lactation Cookies
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
36 participants
Where
1 siteLebanon
Study dates
25 Jun 2025to 25 Sep 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Women 1 month postpartum
  • Exclusively breastfeeding
  • Aged 18-45 years
  • Healthy term infants (≥37 weeks gestation)
  • Uncomplicated pregnancies and births
  • Residing in Lebanon
Show all 9Show fewer
  • Planning to exclusively breastfeed for at least 2 months
  • Intending to attend recommended pediatrician visits
  • Infants must be at least 1 month old

Who cannot join

  • Twin pregnancy
  • Allergies or dislike of ingredients in the study cookies
  • Presence of any health condition including: thyroid disease, epilepsy, psychosis, or bipolar disorder
  • Currently receiving treatment for depression or anxiety
  • Mastitis
  • Smoking or alcohol consumption
  • Taking medications or substances that may affect milk production, including: metoclopramide, chlorpromazine, domperidone, herbal galactagogues, thyroid hormones, or blood thinning medications

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Maria Aoun, Msc contact

+961 70717124

mmaoun02@ndu.edu.lb

Lebanon1 site
  • Keserwan Medical Center

    Jounieh

    Labiba Dahdah, MPH, +961 9 857300 ext. 7953, ld01@kmc.com.lb

    Jessy El Hayek, PhD

Other trials in Lebanon

About this study

Official title: The Effect of Lactation Cookies on Breastfeeding Outcomes: A Pilot Randomized-Controlled Trial

The goal of this clinical trial is to learn if eating lactation cookies can help breastfeeding women make more milk. The main questions it aims to answer are:

  • Do lactation cookies help increase milk production?
  • Do lactation cookies make the breastfeeding experience easier or better?

Researchers will compare lactation cookies to regular cookies to see if lactation cookies work better.

Participants will:

  • Eat 2 cookies every day for 30 days
  • Visit the clinic 2 times, at the start and end of the study
  • Keep a simple record of their breastfeeding and cookie eating
Read the detailed description

Lactation cookies are popular among breastfeeding mothers because they often contain certain ingredients, such as fenugreek, ginger, and moringa, that are believed to help increase milk supply. Despite their widespread use, there is limited scientific evidence to confirm whether these cookies effectively increase breast milk volume or improve the breastfeeding experience.

This randomized controlled trial aims to evaluate the effects of lactation cookies on milk production and breastfeeding outcomes among exclusively breastfeeding mothers. Participants will be randomly assigned to consume a total of 2 cookies per day for 30 days; the cookies will either be lactation cookies or control cookies lacking milk-enhancing ingredients. Breast milk volume will be measured at the beginning and end of the study using standardized collection methods. Additional data will be collected to assess breastfeeding experience and any changes in infant feeding patterns.

This study will help clarify whether lactation cookies provide measurable benefits for breastfeeding mothers and their infants. The findings may support breastfeeding women and guide recommendations on the use of dietary galactagogues like lactation cookies.

Conditions
Breastfeeding
Being tested
Lactation Cookies, Control Cookies
Keywords
Lactation, Breastfeeding, Galactagogues, Milk production, Randomized controlled trial, Lactation cookies
Medical subject headings
Breast Feeding

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Lactation CookiesOther

    Participants will consume 2 cookies per day (approximately 40g daily) for 30 consecutive days. The lactation cookies contain ingredients commonly believed to enhance milk production, including moringa, fenugreek, and ginger.

  • Control CookiesOther

    Participants in the control group will consume 2 cookies per day (approximately 40g total) for 30 consecutive days. These cookies are matched in taste, appearance, and caloric content but do not contain any known galactagogue ingredients.

Study groups in NCT07030491
Study groupRoleWhat they receive
Lactation CookiesExperimentalParticipants in this group will consume 2 lactation cookies daily for 30 days.
Receives: Other: Lactation Cookies
Control CookiesPlacebo comparatorParticipants in this group will consume 2 control cookies (without active ingredients) daily for 30 days.
Receives: Other: Control Cookies

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in breast milk volume from baseline to 1 month post-intervention

    Breast milk volume will be assessed using the 3-hour milk expression protocol developed by Lai et al. (2010). This method involves hourly milk expression sessions over a 3-hour period, during which milk synthesis reaches a steady state, allowing for accurate estimation of the milk production rate.

    Measured: 1 month

Secondary outcomes (11)
  1. Change in breastfeeding self-efficacy scores from baseline to 1 month post-intervention

    Assessed using the Breastfeeding Self-Efficacy Scale-Short Form (BSES-SF), a 14-item scale with scores ranging from 14 to 70, where higher scores indicate greater breastfeeding confidence.

    Measured: 1 month

  2. Anxiety score changes from baseline to 1-month post intervention

    Assessed using the State-Trait Anxiety Inventory (STAI), which includes two 20-item scales (State and Trait anxiety) scored 20-80; higher scores indicate higher anxiety levels.

    Measured: 1 month

  3. Changes in perceived milk supply scores from baseline to 1-month post intervention

    Assessed using the McCarter-Spaulding PIM questionnaire, with scores ranging from 5 to 50, where higher scores indicate greater perceived milk sufficiency.

    Measured: 1 month

  4. Changes in postnatal depression scores from baseline to 1-month post intervention

    Assessed using the Edinburgh Postnatal Depression Scale (EPDS), a 10-item scale with scores ranging from 0 to 30; higher scores indicate more severe depressive symptoms. Scores ≥13 suggest possible depression

    Measured: 1 month

  5. Change in infant weight from baseline to 1 month post-intervention

    Infant weight will be measured in kilograms (kg) using a calibrated infant scale by a pediatrician at baseline and after 1 month to assess changes in growth. Weight data will be interpreted using appropriate weight-for-age growth scores based on WHO growth standards.

    Measured: 1 month

  6. Change in infant length from baseline to 1 month post-intervention

    Infant length will be measured in centimeters (cm) using an infantometer or measuring board by a pediatrician at baseline and after 1 month to assess changes in linear growth. Length data will be interpreted using appropriate length-for-age growth scores based on WHO growth standards.

    Measured: 1 month

  7. Change in infant head circumference from baseline to 1 month post-intervention

    Infant head circumference will be measured in centimeters (cm) using a non-stretchable measuring tape by a pediatrician at baseline and after 1 month to assess brain growth and development. Head circumference data will be interpreted using appropriate head circumference-for-age growth scores based on WHO growth standards.

    Measured: 1 month

  8. Change in number of wet diapers from baseline to 1 month

    The number of wet diapers per day will be recorded by the mother using self-reported logs throughout the 1-month intervention period to assess hydration status and feeding adequacy.

    Measured: 1 month

  9. Change in number of soiled diapers from baseline to 1 month

    The number of soiled diapers per day will be recorded by the mother using self-reported logs throughout the 1-month intervention period to assess digestive health and feeding adequacy.

    Measured: 1 month

  10. Change in breast milk composition from baseline to 1 month post-intervention

    A 15 milliliter (mL) sample of breast milk will be collected from the mother at baseline and after 1 month to assess changes in milk composition. Analyses will focus on nutrient content and the potential transfer of bioactive components from the lactation cookies, including macronutrients (grams per liter, g/L), omega-3 fatty acids (milligrams per deciliter, mg/dL), and other relevant biomarkers.

    Measured: 1 month

  11. Change in infant weight before and after each feed from baseline to 1 month post-intervention

    Infant weight will be measured in kilograms (kg) using a calibrated infant scale immediately before and after each feeding session at baseline and later on Day 30. The difference between pre- and post-feed weights will be calculated to estimate milk intake per feed.

    Measured: 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Jun 2025
  2. Study start25 Jun 2025 (estimated)
  3. Primary completion25 Sep 2025 (estimated)
  4. Study completion25 Sep 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of two groups (lactation cookies or control cookies) and will remain in their group for the 30-day intervention period.
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
36 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07030491
Sponsor's protocol ID
IRB 202425
Status last verified
Jun 2025
First submitted
29 May 2025
Last updated
22 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Roznowski DM, Wagner EA, Riddle SW, Nommsen-Rivers LA. Validity of a 3-Hour Breast Milk Expression Protocol in Estimating Current Maternal Milk Production Capacity and Infant Breast Milk Intake in Exclusively Breastfeeding Dyads. Breastfeed Med. 2020 Oct;15(10):630-638. doi: 10.1089/bfm.2019.0182. Epub 2020 Jul 16.

    PubMed 32700964
  • Lai CT, Hale TW, Simmer K, Hartmann PE. Measuring milk synthesis in breastfeeding mothers. Breastfeed Med. 2010 Jun;5(3):103-7. doi: 10.1089/bfm.2009.0074.

    PubMed 20433368
  • Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry. 1987 Jun;150:782-6. doi: 10.1192/bjp.150.6.782.

    PubMed 3651732
  • Dennis CL. The breastfeeding self-efficacy scale: psychometric assessment of the short form. J Obstet Gynecol Neonatal Nurs. 2003 Nov-Dec;32(6):734-44. doi: 10.1177/0884217503258459.

    PubMed 14649593
  • McCarter-Spaulding DE, Kearney MH. Parenting self-efficacy and perception of insufficient breast milk. J Obstet Gynecol Neonatal Nurs. 2001 Sep-Oct;30(5):515-22. doi: 10.1111/j.1552-6909.2001.tb01571.x.

    PubMed 11572532
  • Palacios AM, Cardel MI, Parker E, Dickinson S, Houin VR, Young B, Allison DB. Effectiveness of lactation cookies on human milk production rates: a randomized controlled trial. Am J Clin Nutr. 2023 May;117(5):1035-1042. doi: 10.1016/j.ajcnut.2023.03.010. Epub 2023 Mar 14.

    PubMed 36921902

Questions about this trial

What is this clinical trial studying?

A study testing Lactation Cookies in people with Breastfeeding, run by Notre Dame University - Louaize at 1 site in Lebanon.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 22 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Lebanon. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jessy El Hayek, PhD (+961 9 218 950 ext. 2848, jelhayek@ndu.edu.lb), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in breast milk volume from baseline to 1 month post-intervention (time frame: 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07030491, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in